Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for immune-mediated cancer therapy

Compositions and methods for immune-mediated cancer therapy

US Patent 12350275 · Granted Jul 8, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GPC3-targeting drug which is administered to patient responsive to GPC3-targetin2023
Compositions and methods for immune-mediated cancer therapy2022
Rationale-based design of a targeted therapy for cancer2019
Induction of tumor hypoxia for cancer therapy2019
Induction of tumor hypoxia for cancer therapy2018
Rationale-based design of a targeted therapy for cancer2017
Induction of tumor hypoxia for cancer therapy2017
Induction of tumor hypoxia for cancer therapy2013
Stilbene derivatives as new cancer therapeutic agents2010